SHILPA MEDICARE LIMITED Patent applications |
Patent application number | Title | Published |
20160122315 | CRYSTALLINE IMATINIB MESYLATE PROCESS - The present invention relates to a process for preparation of crystalline non-needle shaped Form-SA of Imatinib mesylate (I). | 05-05-2016 |
20160060220 | PROCESS FOR PREPARATION OF 2-CHLORO-N-(4-CHLORO-3-PYRIDIN-2-YLPHENYL)-4-METHYLSULFONYLBENZAMIDE SOLID FORMS - The present invention relates to crystalline 2-Chloro-N-(4-chloro-3-pyridin-2-ylphenyl)-4-methylsulfonylbenzamide (I) designated as Form-SV and process for preparation thereof. | 03-03-2016 |
20150344409 | PROCESS FOR THE PREPARATION OF FINGOLIMOD AND ITS SALTS - The present invention provides process for preparation of Fingolimod hydrochloride (I). | 12-03-2015 |
20150315164 | PROCESS FOR PREPARING AMORPHOUS CABAZITAXEL - The present invention provides a process for preparing amorphous Cabazitaxel from the solvate form of Cabazitaxel. | 11-05-2015 |
20150284421 | FORMULATION OF 5-AZACYTIDINE - The present invention relates to lyophilized formulations comprising crystalline 5-azacytidine and process for preparing lyophilized formulations comprising crystalline 5-azacytidine. | 10-08-2015 |
20150259364 | CRYSTALLINE BORTEZOMIB PROCESS - The present invention provides process for preparation of crystalline Bortezomib (Ia) as its monohydrate which is designated as crystalline Form-SB | 09-17-2015 |
20150259348 | PROCESS FOR PREPARING PEMETREXED DI POTASSIUM AND ITS HYDRATES - The present invention provides Di potassium (S)-2-(4-(2-(2-amino-4-oxo-4,7-dihydro-3H-pyrrolo[2,3-d]pyrimidin-5-yl)ethyl)benzamido)pentanedioate (I) | 09-17-2015 |
20140336246 | PROCESS FOR PREPARING AMORPHOUS CABAZITAXEL - The present invention provides a non-solvated amorphous form of (2α,5β,7β,10β,13α)-4-acetoxy-13-({(2R,3S)-3[ (tert-butoxy carbonyl) amino]-2-hydroxy-3-phenylpropanoyl}oxy)-1-hydroxy-7,10-dimethoxy-9-oxo-5,20-epoxytax-11-en-2-yl benzoate or Cabazitaxel (I), | 11-13-2014 |